On Invalid Date, Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 2022 earnings per share (EPS) of -$0.17, up 34.62% year over year. Total Cumberland Pharmaceuticals earnings for the quarter were -$2.44 million. In the same quarter last year, Cumberland Pharmaceuticals's earnings per share (EPS) was -$0.26.
As of Q1 2023, Cumberland Pharmaceuticals's earnings has grown year over year. Cumberland Pharmaceuticals's earnings in the past year totalled -$5.57 million.
What is CPIX's earnings date?
Cumberland Pharmaceuticals's earnings date is Invalid Date. Add CPIX to your watchlist to be reminded of CPIX's next earnings announcement.
What was CPIX's revenue last quarter?
On Invalid Date, Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 2022 revenue of $9.12 million up 9.66% year over year. In the same quarter last year, Cumberland Pharmaceuticals's revenue was $8.32 million.
What was CPIX's revenue growth in the past year?
As of Q1 2023, Cumberland Pharmaceuticals's revenue has grown 16.75% year over year. This is 240.97 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 257.72%. Cumberland Pharmaceuticals's revenue in the past year totalled $42.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.